How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are the population and subgroups appropriate and described correctly?

  • Question on Consultation

    Are the interventions described correctly?

  • Question on Consultation

    Are there any other technologies that should be included in the assessment?

  • Question on Consultation

    Have the care pathway and comparator been appropriately described?

  • Question on Consultation

    Is the place of the technologies in the pathway described appropriately?

  • Question on Consultation

    Are livers typically split at paediatric liver transplant centres?

  • Question on Consultation

    Are all of the outcomes suitable for inclusion in the assessment?

  • Question on Consultation

    Are there any additional outcomes which should be included, particularly for children and young people?

  • Question on Consultation

    Which outcomes are most relevant to children and young people?

  • Question on Consultation

    Are there any other patient issues that should be considered?

  • Question on Consultation

    Are there any other issues for the implementation and adoption of ex-situ machine technologies for liver transplants?

  • Question on Consultation

    Are there any changes that need to be made to the scope to eliminate unlawful discrimination and promote equality?

  • Question on Consultation

    Are there any additional potential equality or discrimination issues associated with this topic that need to be considered?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Ex-situ machine perfusion devices for deceased donor liver transplants

Closed for comments This consultation ended on at   Request commenting lead permission

Appendix A: Abbreviations

CYP

Children and young people

DBD

Donated after brainstem death (death that has been confirmed using neurological criteria)

DCD

Donated after circulatory death (death that has been confirmed using cardio-respiratory criteria)

ICU

Intensive care unit

MHRA

Medicines and Healthcare products Regulatory Agency

NRP

Normothermic regional perfusion

SCS

Static cold storage